IPSWICH-BASED Biotec Laboratories, has announced it is seeking to raise £250,000-£500,000 as it heads towards a flotation on the London Stock Exchange's Alternative Investment Market (AIM).
IPSWICH-BASED Biotec Laboratories, has announced it is seeking to raise £250,000-£500,000 as it heads towards a flotation on the London Stock Exchange's Alternative Investment Market (AIM).
Biotec Laboratories, a developer and manufacturer of medical diagnostics products, plans to raise funds on AIM to expand international sales of its new lead tuberculosis diagnostic product called FASTPlaqueTB™.
FASTPlaqueTB™ is a patented diagnostic kit that offers considerable benefits over older, less advanced TB diagnostic technologies.
These include rapid detection, lower cost and much higher accuracy.
Biotec Laboratories is based in Martlesham Heath, near Ipswich, where it employs around 30 people.
With the funds it hopes to raise on AIM, the company expects to increase marketing and production which would result in increased employment.
Interested investors can contact Matthew Durdy at 01473 612158.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here